Skip to main content
. Author manuscript; available in PMC: 2017 Feb 10.
Published in final edited form as: Sci Transl Med. 2016 Jul 27;8(349):349ra100. doi: 10.1126/scitranslmed.aaf5103

Fig. 5. Human breast milk oligosaccharide (HMO) composition and the infant stool microbiome.

Fig. 5

(A) The HMO composition of breast milk based on maternal HIV status. Unadjusted p values </=0.1 are shown. (B) Significant associations between specific HMOs and bacterial families. Blue bars represent HIV-unexposed infants. Red bars represent HIV-exposed, uninfected infants. Spearman correlation coefficients are plotted along the x-axis. (C) The infant’s stool relative maturity compared to the HMO composition of mother’s breast milk using Spearman correlations. The two HMOs with fdr_p values <0.1 are presented: LNT and 3FL. (2′FL= 2′-fucosyllactose; 3FL= 3-fucosyllactose; LNnT= lacto-N-neotetraose; 3′SL= 3′-sialyllactose; LNT= lacto-N-tetraose; LNFP-1= lacto-N- fucopentaose 1; LNFP-2= lacto-N- fucopentaose 2; LNFP-3= lacto-N- fucopentaose 3; LSTb= sialyllacto-N-tetraose b; LSTc= sialyllacto-N-tetraose c; DFLNT= difucosialyllacto-N-tetraose; DSLNT= disialyllacto-N-tetraose; FLNH= fucosyllacto-N-hexaose; DFLNH= difucosyllacto-N-hexaose; FDSLNH= fucosyl-disialyllacto-N-hexaose; DSLNH= disialyllacto-N-hexaose)